Glaxo regret over China 'bribery'

Updated
GlaxoSmithKline
GlaxoSmithKline

Drugs giant GlaxoSmithKline expressed regret over "shameful" alleged bribery of doctors and health officials by its executives in China.

Millions of pounds were said to have been funnelled through travel agencies over six years while "sexual bribery" was also alleged to have been used, according to reports in China.
%VIRTUAL-SkimlinksPromo%

Advertisement